Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.62 |
| ▸ | MEN1 | O00255 | 1/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.58 |
| ▸ | MAPT | P10636 | 1/20 | 0.55 |
| ▸ | LAP3 | P28838 | 3/20 | 0.53 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.51 |
| ▸ | GRN | P28799 | 2/20 | 0.50 |
| ▸ | SORT1 | Q99523 | 2/20 | 0.50 |
| ▸ | MME | P08473 | 1/20 | 0.50 |
| ▸ | CTSC | P53634 | 1/20 | 0.47 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.47 |
| ▸ | PLA2G2A | P14555 | 2/20 | 0.46 |
| ▸ | PLA2G5 | P39877 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL65868 | 1.00 | ALDH1A1 (0.62) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL65869 | 1.00 | ALDH1A1 (0.62) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL9576054 | 0.93 | ALDH1A1 (0.55) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL29645227 | 0.88 | MME (0.53) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| Leucine SCHEMBL28698190 | 0.88 | SLC7A5 (0.56) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL29645226 | 0.88 | MME (0.53) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL1674751 | 0.88 | ALDH1A1 (0.53) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL1674750 | 0.88 | ALDH1A1 (0.53) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL18613505 | 0.88 | ALDH1A1 (0.53) | ALDH1A1MEN1LMNAKMT2AMAPT | |
| SCHEMBL8017457 | 0.88 | ALDH1A1 (0.53) | ALDH1A1MEN1LMNAKMT2AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118406439-B | Chemical mechanical polishing composition and application thereof in tungsten chemical mechanical polishing | 万华化学集团电子材料有限公司 | 2024-10-18 | — | — | CN | claimed |
| CN-118406439-A | Chemical mechanical polishing composition and application thereof in tungsten chemical mechanical polishing | 万华化学集团电子材料有限公司 | 2024-07-30 | — | — | CN | claimed |
| CN-117446785-A | Preparation method and application of carbon quantum dot corrosion inhibitor | 黔南民族师范学院 | 2024-01-26 | — | — | CN | claimed |
| CN-108218375-B | Green and environment-friendly aerated concrete block and preparation method thereof | 青岛广润丰建筑材料有限责任公司 | 2021-06-22 | — | — | CN | claimed |
| US-20260144818-A1 | ARMED CHIMERIC RECEPTORS AND METHODS OF USE THEREOF | SENTI BIOSCIENCES, INC. (US) | 2026-05-28 | — | — | US | disclosed |
| US-12622975-B2 | Peptide-conjugated prodrugs | BRANDEIS UNIVERSITY (US) | 2026-05-12 | — | — | US | disclosed |
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4180814-B1 | MARKERS OF ENDOMETRIAL CANCER | FUNDACIO HOSPITAL UNIV VALL DHEBRON INSTITUT DE RECERCA (ES) | 2026-03-04 | — | — | EP | disclosed |
| EP-4610655-A2 | MARKERS OF ENDOMETRIAL CANCER | Fundació Hospital Universitari Vall d'Hebron - Institut de Recerca (ES) | 2025-09-03 | — | — | EP | disclosed |
| EP-4593631-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | Mars, Incorporated (US) | 2025-08-06 | — | — | EP | disclosed |
| US-20250229001-A1 | ANCHORED CELL CONSTRUCT CULTURE | CAROMEATS INC (CA) | 2025-07-17 | — | — | US | disclosed |
| US-20250129415-A1 | POLYNUCLEOTIDE SEQUENCING USING IONOPHORES | ILLUMINA, INC. (US) | 2025-04-24 | — | — | US | disclosed |
| WO-2023278750-A1 | POLYNUCLEOTIDE SEQUENCING USING IONOPHORES | ILLUMINA, INC. (US) | 2023-01-05 | — | — | WO | disclosed |
| US-20220387610-A1 | PEPTIDE-CONJUGATED PRODRUGS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2022-12-08 | — | — | US | disclosed |
| US-20220291237-A1 | Gene Expression Inflammatory Age and Its Uses | Edifice Health, Inc. (US) | 2022-09-15 | — | — | US | disclosed |
| WO-2022187087-A1 | GENE EXPRESSION INFLAMMATORY AGE AND ITS USES | Edifice Health, Inc. (US) | 2022-09-09 | — | — | WO | disclosed |
| WO-2022143532-A1 | METHOD FOR SYNTHESIZING PEPTIDE THIOESTERS AND HEAD-TO-TAIL AMIDE CYCLIC PEPTIDE THEREOF | 江苏金斯瑞生物科技有限公司 | 2022-07-07 | — | — | WO | disclosed |
| US-20220090040-A1 | Fusion Constructs for Controlling Protein Function | SENTI BIOSCIENCES, INC. (US) | 2022-03-24 | — | — | US | disclosed |
| CN-108218375-B | Green and environment-friendly aerated concrete block and preparation method thereof | 青岛广润丰建筑材料有限责任公司 | 2021-06-22 | — | — | CN | disclosed |
| CN-108218375-B | Green and environment-friendly aerated concrete block and preparation method thereof | 青岛广润丰建筑材料有限责任公司 | 2021-06-22 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622975-B2 | Peptide-conjugated prodrugs | PEPD, PAM, VIP | ALDH1A1 3596/4885MEN1 1217/4885LMNA 1538/4885 |
| US-20220387610-A1 | PEPTIDE-CONJUGATED PRODRUGS | VIP, DNPEP, PEPD | ALDH1A1 4110/4885MEN1 1147/4885LMNA 3184/4885 |
| US-20260144818-A1 | ARMED CHIMERIC RECEPTORS AND METHODS OF USE THEREOF | TNFRSF9, NGFR, HAVCR2 | ALDH1A1 3556/4885MEN1 2735/4885LMNA 2959/4885 |
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | PIGS, TAS2R13, CEL | ALDH1A1 4390/4885MEN1 3411/4885LMNA 1459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.